Suchergebnisse - "Gulick, Roy M"

PubPharm (101)

1

Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305)

enthalten in: Aids and behavior | 2022

von Mayer, K. | Yuhas, K. | Amico, K. | +23

2

Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

enthalten in: Nature medicine | 2017

von Caskey, M. | Schoofs, T. | Gruell, H. | +34

3

Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

enthalten in: Nature medicine | 2017

von Caskey, M. | Schoofs, T. | Gruell, H. | +34

4

Invasive Aspergillus Sinusitis in Human Immunodeficiency Virus Infection : Case Report and Review of the Literature

enthalten in: Open forum infectious diseases | 2016

von Humphrey, J. | Walsh, T. | Gulick, R.

5

The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United States

enthalten in: Clinical infectious diseases | 2016

von Girouard, M. | Sax, P. | Parker, R. | +6

6

HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

enthalten in: Nature | 2016

von Scheid, J. | Horwitz, J. | Bar-On, Y. | +30

7

Corrigendum: Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117

enthalten in: Nature | 2016

von Caskey, M. | Klein, F. | Lorenzi, J. | +22

8

PHASE 2 STUDY OF THE SAFETY AND TOLERABILITY OF MARAVIROC-CONTAINING REGIMENS TO PREVENT HIV INFECTION IN MEN WHO HAVE SEX WITH MEN (MSM) (HPTN 069/ACTG A5305)

enthalten in: The journal of infectious diseases | 2016

von Gulick, R. | Wilkin, T. | Chen, Y. | +26

9

PHASE 2 STUDY OF THE SAFETY AND TOLERABILITY OF MARAVIROC-CONTAINING REGIMENS TO PREVENT HIV INFECTION IN MEN WHO HAVE SEX WITH MEN (MSM) (HPTN 069/ACTG A5305)

enthalten in: The journal of infectious diseases | 2016

von Gulick, R. | Wilkin, T. | Chen, Y. | +26

10

Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery

enthalten in: Aids | 2015

von Cillo, A. | Hilldorfer, B. | Lalama, C. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]